Source: Geron Corporation
Posted: May 17, 2007 07:30 AM EDT
Summary:
In an official press release, Geron Corporation announced that its scientists and collaborators at the University of Alberta have differentiated human embryonic stem cells (hESCs) into islet-like clusters (ILCs) that secrete insulin in response to elevated glucose levels. The studies demonstrate the feasibility of producing therapeutic cell types from hESCs for the treatment of diabetes.
